INDEL Length and Haplotypes in the β-Synuclein Gene: A Key to Differentiate Dementia with Lewy Bodies?
暂无分享,去创建一个
A. Ariza | K. Beyer | Júlia Canet-Pons | Aintzane Urbizu | Ana Gámez-Valero | Cristina Santos | Ana Anillo
[1] R. Nussbaum. Genetics of Synucleinopathies. , 2018, Cold Spring Harbor perspectives in medicine.
[2] D. Galasko. Lewy Body Disorders. , 2017, Neurologic clinics.
[3] M. Montico,et al. SNCA 3′UTR genetic variants in patients with Parkinson’s disease and REM sleep behavior disorder , 2017, Neurological Sciences.
[4] Alexander K. Buell,et al. β-Synuclein suppresses both the initiation and amplification steps of α-synuclein aggregation via competitive binding to surfaces , 2016, Scientific Reports.
[5] M. Ingelsson. Alpha-Synuclein Oligomers—Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders , 2016, Front. Neurosci..
[6] Ekaterina Nosova,et al. α‐synuclein genetic variability: A biomarker for dementia in Parkinson disease , 2016, Annals of neurology.
[7] Yonatan Stelzer,et al. Parkinson-associated risk variant in enhancer element produces subtle effect on target gene expression , 2016, Nature.
[8] A. Roses,et al. A cytosine-thymine (CT)-rich haplotype in intron 4 of SNCA confers risk for Lewy body pathology in Alzheimer's disease and affects SNCA expression , 2015, Alzheimer's & Dementia.
[9] Andrei L. Turinsky,et al. The missing indels: an estimate of indel variation in a human genome and analysis of factors that impede detection , 2015, Nucleic acids research.
[10] Jinrong Zhao,et al. Alpha‐synuclein (SNCA) polymorphisms and susceptibility to Parkinson's disease: A meta‐analysis , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[11] Josephine A. Wright,et al. Counter-regulation of alpha- and beta-synuclein expression at the transcriptional level , 2013, Molecular and Cellular Neuroscience.
[12] M. Farrer,et al. SNCA, MAPT, and GSK3B in Parkinson disease: a gene–gene interaction study , 2011, European journal of neurology.
[13] O. Combarros,et al. Replication of MAPT and SNCA, but not PARK16‐18, as susceptibility genes for Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[14] Ryan E. Mills,et al. Natural genetic variation caused by small insertions and deletions in the human genome. , 2011, Genome research.
[15] Sebastian M. Armasu,et al. Common variants in PARK loci and related genes and Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[16] E. Tolosa,et al. The decrease of β-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies. , 2010, Brain : a journal of neurology.
[17] D. Galasko,et al. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level. , 2010, Archives of neurology.
[18] Christian Wider,et al. Association of alpha-, beta-, and gamma-Synuclein with diffuse lewy body disease. , 2010, Archives of neurology.
[19] L. Excoffier,et al. Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows , 2010, Molecular ecology resources.
[20] Eden R Martin,et al. Genome‐Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease , 2010, Annals of human genetics.
[21] Sonja W. Scholz,et al. Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease , 2009, Nature Genetics.
[22] D. Ge,et al. Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human α-synuclein in transgenic mouse brain , 2009, Human molecular genetics.
[23] Thomas D. Schmittgen,et al. Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.
[24] D. Berg,et al. Genetic variability in the SNCA gene influences α‐synuclein levels in the blood and brain , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] D. Eliezer,et al. Residual structure, backbone dynamics, and interactions within the synuclein family. , 2007, Journal of molecular biology.
[26] Walter A. Rocca,et al. Beta-synuclein gene variants and Parkinson's disease: A preliminary case-control study , 2007, Neuroscience Letters.
[27] E. Tolosa,et al. A variable poly‐T sequence modulates α‐synuclein isoform expression and is associated with aging , 2007 .
[28] Thomas Unger,et al. Quantitative real-time RT-PCR data analysis: current concepts and the novel “gene expression’s CT difference” formula , 2006, Journal of Molecular Medicine.
[29] Aldo Quattrone,et al. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. , 2006, JAMA.
[30] S Minoshima,et al. Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.
[31] M. Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[32] Philippe Amouyel,et al. α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.
[33] Janel O. Johnson,et al. α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.
[34] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[35] D. Aarsland,et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.
[36] Sebastian Doniach,et al. Biophysical Properties of the Synucleins and Their Propensities to Fibrillate , 2002, The Journal of Biological Chemistry.
[37] R. Nussbaum,et al. Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system. , 2001, Human molecular genetics.
[38] Makoto Hashimoto,et al. β-Synuclein Inhibits α-Synuclein Aggregation A Possible Role as an Anti-Parkinsonian Factor , 2001, Neuron.
[39] J. Trojanowski,et al. Altered expression of the synuclein family mRNA in Lewy body and Alzheimer’s disease , 2001, Brain Research.
[40] Matthew J. Farrer,et al. α-synuclein gene haplotypes are associated with Parkinson’s disease , 2001 .
[41] A. Destée,et al. No pathogenic mutations in the β-synuclein gene in Parkinson's disease , 1999, Neuroscience Letters.
[42] Olaf Riess,et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.
[43] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[44] H. Braak,et al. Diagnostic Criteria for Neuropathologic Assessment of Alzheimer’s Disease , 1997, Neurobiology of Aging.
[45] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[46] A. Dehejia,et al. Human and mouse alpha-synuclein genes: comparative genomic sequence analysis and identification of a novel gene regulatory element. , 2001, Genome research.